Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok

October 29, 2008

The IOF World Congress on Osteoporosis, the largest scientific conference devoted primarily to osteoporosis, will open on December 3rd in Bangkok with a special session focused on four key topics in nutrition and bone health.

Professor Cyrus Cooper, Director of the MRC Epidemiology Resource Centre at the University of Southampton; and Norman Collisson Chair of Musculoskeletal Sciences at the University of Oxford, will speak on the developmental origins of osteoporosis.

He will outline recent studies that show how adverse influences during fetal development or immediately after birth independently affect the later risk of osteoporotic fracture.

The role of bone growth and nutrition will be reviewed by Professor René Rizzoli, Head of the Division of Bone Diseases (WHO Collaborating Center for Osteoporosis Prevention), Faculty of Medicine, Geneva University Hospitals. He will discuss recent studies that show how a combination of optimal nutritional intake and environmental factors (such as exercise) in childhood and adolescence helps individuals optimize their largely genetically determined peak bone mass.

Epidemiological evidence that has shown associations between poor vitamin K nutrition and age-related bone loss in elderly men and women will be outlined by Dr. Sarah Booth, Senior Scientist and Director of the Vitamin K laboratory at the Jean Mayer Human Nutrition Research Center on Aging at Tufts University in Boston.

Professor Bess Dawson-Hughes, Professor of Medicine and Director of the Metabolic Bone Disease Clinic at Tufts New England Medical Center, Tufts University will review the important role of protein and discuss how its interaction with calcium impacts on bone mineral density and fracture risk.

The Nutrition and Bone Health Session, one of four special focused sessions, will be held during the morning of December 3, 2007 prior to the official opening of the IOF World Congress on Osteoporosis in Bangkok.

To view the complete scientific program and for online registration please visit http://www.iofbonehealth.org/wco/2008/homepage.html
-end-
Osteoporosis, in which the bones become porous and break easily, is one of the world's most common and debilitating diseases. The result: pain, loss of movement, inability to perform daily chores, and in many cases, death. One out of three women over 50 will experience osteoporotic fractures, as will one out of five men 1,2,3.. Unfortunately, screening for people at risk is far from being a standard practice. Osteoporosis can, to a certain extent, be prevented, it can be easily diagnosed and effective treatments are available.

The International Osteoporosis Foundation (IOF) is the only worldwide organization dedicated to the fight against osteoporosis. It brings together scientists, physicians, patient societies and corporate partners. Working with its 188 member societies in 91 locations, and other healthcare-related organizations around the world, IOF encourages awareness and prevention, early detection and improved treatment of osteoporosis.

IOF World Congress on Osteoporosis, held every two years, is the only global congress dedicated specifically to all aspects of osteoporosis. Besides the opportunity to learn about the latest science and developments in diagnosis, treatment and the most recent socio-economic studies, participants have the chance to meet and exchange ideas with other physicians from around the world. All aspects of osteoporosis will be covered during the Congress which will comprise lectures by invited speakers presenting cutting edge research in the field, and a large number of oral presentations and poster sessions selected from submitted abstracts. Meet the Expert Sessions covering 22 key topics relating to diagnosis and management of osteoporosis are also on the program.

1. Melton U, Chrischilles EA, Cooper C et al. How many women have osteoporosis? Journal of Bone Mineral Research, 1992; 7:1005-10
2. Kanis JA et al. Long-term risk of osteoporotic fracture in Malmo. Osteoporosis International, 2000; 11:669-674
3. Melton LJ, et al. Bone density and fracture risk in men. JBMR. 1998; 13: No 12:1915

For more information on osteoporosis and IOF please visit: http://www.iofbonehealth.org

For more information please contact:

International Osteoporosis Foundation
Tel. +41 22 994 0100
E-mail: news@iofbonehealth.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.